-

GE HealthCare Announces Collaboration with DePuy Synthes to Bring Advanced 3D Precision Imaging Innovation to Spine Practices in the United States

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has entered into a distribution agreement with DePuy Synthes*, the Orthopaedics Company of Johnson & Johnson, to bring GE HealthCare’s OEC 3D Imaging System, in conjunction with DePuy Synthes’ extensive product portfolio, to more surgeons and patients across the United States. This new collaboration demonstrates GE HealthCare’s ongoing commitment to bring exceptional imaging technologies to clinicians providing patient care through the practice of some of healthcare’s most complex spine procedures today.

The spine is a crucial structure to the human body and highly complex in its composition of muscles, bones, tendons, ligaments, and sensitive nerves. Injuries or deformities of the spine can affect any appendage of the body and significantly restrict mobility as well as reduce quality of life as a result. Visualization and imaging are critical to helping achieve accurate diagnosis as well as treatment in the face of such complexity to ensure the most optimal patient outcome.

GE HealthCare’s OEC 3D Imaging System was designed to increase surgical imaging precision and efficiency to further the 3D imaging experience in surgical suites practicing spine procedures every day. The OEC 3D surgical imaging C-arm is a mobile CBCT imaging solution that works to seamlessly enable intraoperative 3D volumes and 2D high-definition imaging while covering a large anatomical field of view. With precise 3D volumetric images and familiar OEC 2D imaging capabilities, the OEC 3D C-arm also includes features for analyzing images, noise reduction, interoperative review, and seamless workflow to help clinicians see a broader picture.

With demand for minimally invasive surgical procedures continuing to grow and ambulatory surgery centers performing more than half of all outpatient procedures in the United States1, providers need efficient imaging capabilities. This new agreement will help enable both companies to better serve surgeons and address the complex needs of their patients and a wide range of procedural needs in spine.

“We know that GE HealthCare’s OEC 3D is a game-changer for clinicians today – from its large field of view and open platform to high-quality reconstructed 3D images,” said Phil Rackliffe, President & CEO for GE Healthcare’s Image-Guided Therapies business. “Through this new collaboration with DePuy Synthes, we’re excited for the opportunity to bring this technology to more spine practices in acute to outpatient settings knowing OEC 3D provides precise and efficient imaging so that surgeons can stay focused on what matters most, providing quality patient care.”

* DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.

______________________________
1
https://www.healthcarefinancenews.com/news/ambulatory-surgery-centers-compete-hospitals-outpatient-dollars

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on Facebook, LinkedIn, Twitter, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.

Contacts

Emily Dalton Niles, Global Communications Leader for WHXR & IGT
Emily.Niles@ge.com

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Release Summary
GE HealthCare has entered into a distribution agreement with DePuy Synthes to bring OEC 3D Imaging System to more surgeons and patients in U.S.
Release Versions

Contacts

Emily Dalton Niles, Global Communications Leader for WHXR & IGT
Emily.Niles@ge.com

More News From GE HealthCare Technologies Inc.

GE HealthCare expands mammography collaboration with RadNet’s DeepHealth subsidiary to extend global access to DeepHealth’s AI-powered breast cancer screening solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and w...

GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced a digital integration between the GE HealthCare bkActiv™ intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during cranial procedures to complement surgical planning and navigation workflows. This integration builds on an existing strategic alliance between the companies to accelerate next-generation technology innovati...

GE HealthCare to announce first quarter 2026 results on April 29, 2026

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will...
Back to Newsroom